116 related articles for article (PubMed ID: 16966297)
1. Parotitis associated with a parainfluenza virus type 3 infection during aplasia after unrelated allogeneic stem cell transplantation.
Lange T; Franke G; Niederwieser D
Leuk Lymphoma; 2006 Aug; 47(8):1714-5. PubMed ID: 16966297
[No Abstract] [Full Text] [Related]
2. Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy.
Chakrabarti S; Collingham KE; Holder K; Oyaide S; Pillay D; Milligan DW
Clin Infect Dis; 2000 Dec; 31(6):1516-8. PubMed ID: 11096028
[TBL] [Abstract][Full Text] [Related]
3. Long-term therapy with aerosolized ribavirin for parainfluenza 3 virus respiratory tract infection in an infant with severe combined immunodeficiency.
Stankova J; Carret AS; Moore D; McCusker C; Mitchell D; Davis M; Mazer B; Jabado N
Pediatr Transplant; 2007 Mar; 11(2):209-13. PubMed ID: 17300503
[TBL] [Abstract][Full Text] [Related]
4. Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation.
Casey J; Morris K; Narayana M; Nakagaki M; Kennedy GA
Bone Marrow Transplant; 2013 Nov; 48(12):1558-61. PubMed ID: 23912665
[TBL] [Abstract][Full Text] [Related]
5. Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.
Chakrabarti S; Collingham KE; Holder K; Fegan CD; Osman H; Milligan DW
Bone Marrow Transplant; 2001 Oct; 28(8):759-63. PubMed ID: 11781627
[TBL] [Abstract][Full Text] [Related]
6. Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment.
Elizaga J; Olavarria E; Apperley J; Goldman J; Ward K
Clin Infect Dis; 2001 Feb; 32(3):413-8. PubMed ID: 11170949
[TBL] [Abstract][Full Text] [Related]
7. Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population.
Cortez KJ; Erdman DD; Peret TC; Gill VJ; Childs R; Barrett AJ; Bennett JE
J Infect Dis; 2001 Nov; 184(9):1093-7. PubMed ID: 11598830
[TBL] [Abstract][Full Text] [Related]
8. Guillain-Barré syndrome after allogeneic hematopoietic stem cell transplantation.
Rodriguez V; Kuehnle I; Heslop HE; Khan S; Krance RA
Bone Marrow Transplant; 2002 Mar; 29(6):515-7. PubMed ID: 11960272
[TBL] [Abstract][Full Text] [Related]
9. Control of an outbreak of human parainfluenza virus 3 in hematopoietic stem cell transplant recipients.
Maziarz RT; Sridharan P; Slater S; Meyers G; Post M; Erdman DD; Peret TC; Taplitz RA
Biol Blood Marrow Transplant; 2010 Feb; 16(2):192-8. PubMed ID: 19781656
[TBL] [Abstract][Full Text] [Related]
10. Treatment of parainfluenza virus 3 pneumonia in a cardiac transplant recipient with intravenous ribavirin and methylprednisolone.
Wright JJ; O'driscoll G
J Heart Lung Transplant; 2005 Mar; 24(3):343-6. PubMed ID: 15737764
[TBL] [Abstract][Full Text] [Related]
11. Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation.
Inoue Y; Endo S; Matsuno N; Kikukawa Y; Shichijo T; Koga K; Takaki A; Iwanaga K; Nishimura N; Fuji S; Fukuda T; Nosaka K; Matsuoka M
Bone Marrow Transplant; 2019 Feb; 54(2):338-342. PubMed ID: 30116017
[No Abstract] [Full Text] [Related]
12. A parainfluenza-3 outbreak in a SCT unit: sepsis with multi-organ failure and multiple co-pathogens are associated with increased mortality.
Hodson A; Kasliwal M; Streetly M; MacMahon E; Raj K
Bone Marrow Transplant; 2011 Dec; 46(12):1545-50. PubMed ID: 21258418
[TBL] [Abstract][Full Text] [Related]
13. High incidence of CMV infection in adult T-cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation.
Nakano N; Kubota A; Tokunaga M; Tokunaga M; Itoyama T; Makino T; Takeuchi S; Takatsuka Y; Utsunomiya A
Bone Marrow Transplant; 2014 Dec; 49(12):1548-9. PubMed ID: 25243622
[No Abstract] [Full Text] [Related]
14. Adult T-cell leukemia/lymphoma in donor cells responding to second allogeneic hematopoietic stem cell transplantation using unrelated cord blood: the Nagasaki Transplant Group experience.
Itonaga H; Taguchi J; Taguchi M; Taniguchi H; Sato S; Sawayama Y; Imaizumi Y; Yoshida S; Hata T; Moriuchi Y; Miyazaki Y
Leuk Lymphoma; 2016 Dec; 57(12):2946-2948. PubMed ID: 27210445
[No Abstract] [Full Text] [Related]
15. Successful treatment of parainfluenza virus 3 pneumonia with oral ribavirin and methylprednisolone in a bone marrow transplant recipient.
Shima T; Yoshimoto G; Nonami A; Yoshida S; Kamezaki K; Iwasaki H; Takenaka K; Miyamoto T; Harada N; Teshima T; Akashi K; Nagafuji K
Int J Hematol; 2008 Oct; 88(3):336-340. PubMed ID: 18712461
[TBL] [Abstract][Full Text] [Related]
16. Treatment of parainfluenza 3 infection with DAS181 in a patient after allogeneic stem cell transplantation.
Chen YB; Driscoll JP; McAfee SL; Spitzer TR; Rosenberg ES; Sanders R; Moss RB; Fang F; Marty FM
Clin Infect Dis; 2011 Oct; 53(7):e77-80. PubMed ID: 21880586
[TBL] [Abstract][Full Text] [Related]
17. A daring treatment and a successful outcome: the need for targeted therapies for pediatric respiratory viruses.
DeLaMora P; Moscona A
Pediatr Transplant; 2007 Mar; 11(2):121-3. PubMed ID: 17300487
[No Abstract] [Full Text] [Related]
18. Respiratory virus infections in adult T cell-depleted transplant recipients: the role of cellular immunity.
Chakrabarti S; Collingham KE; Marshall T; Holder K; Gentle T; Hale G; Fegan CD; Milligan DW
Transplantation; 2001 Oct; 72(8):1460-3. PubMed ID: 11685123
[TBL] [Abstract][Full Text] [Related]
19. Parainfluenza type 3 infection post stem cell transplant: high prevalence but low mortality.
Dignan F; Alvares C; Riley U; Ethell M; Cunningham D; Treleaven J; Ashley S; Bendig J; Morgan G; Potter M
J Hosp Infect; 2006 Aug; 63(4):452-8. PubMed ID: 16772104
[TBL] [Abstract][Full Text] [Related]
20. Human parainfluenza type 4 virus (hPIV4) infection provoking many questions regarding the role of this virus as the causative agent of respiratory tract infections in the post-transplant setting.
Hohenthal U; Nikoskelainen J; Vainionpää R; Peltonen R; Routamaa M; Itälä M; Kotilainen P
Bone Marrow Transplant; 2002 Apr; 29(7):629-30. PubMed ID: 11979316
[No Abstract] [Full Text] [Related]
[Next] [New Search]
